ATE443074T1 - Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren - Google Patents

Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren

Info

Publication number
ATE443074T1
ATE443074T1 AT00914799T AT00914799T ATE443074T1 AT E443074 T1 ATE443074 T1 AT E443074T1 AT 00914799 T AT00914799 T AT 00914799T AT 00914799 T AT00914799 T AT 00914799T AT E443074 T1 ATE443074 T1 AT E443074T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid molecules
methods
relates
cloning
Prior art date
Application number
AT00914799T
Other languages
English (en)
Inventor
James Hartley
Michael Brasch
Gary Temple
David Cheo
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Application granted granted Critical
Publication of ATE443074T1 publication Critical patent/ATE443074T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00914799T 1999-03-02 2000-03-02 Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren ATE443074T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12238999P 1999-03-02 1999-03-02
US12604999P 1999-03-23 1999-03-23
US13674499P 1999-05-28 1999-05-28
PCT/US2000/005432 WO2000052027A1 (en) 1999-03-02 2000-03-02 Compositions and methods for use in recombinational cloning of nucleic acids

Publications (1)

Publication Number Publication Date
ATE443074T1 true ATE443074T1 (de) 2009-10-15

Family

ID=27382780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00914799T ATE443074T1 (de) 1999-03-02 2000-03-02 Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren

Country Status (9)

Country Link
US (4) US7670823B1 (de)
EP (3) EP1173460B1 (de)
JP (1) JP4580106B2 (de)
AT (1) ATE443074T1 (de)
AU (2) AU774643B2 (de)
CA (1) CA2363924A1 (de)
DE (1) DE60042969D1 (de)
NZ (2) NZ514569A (de)
WO (1) WO2000052027A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69836092T2 (de) 1997-10-24 2007-05-10 Invitrogen Corp., Carlsbad Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US20030124555A1 (en) * 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
NZ514569A (en) * 1999-03-02 2004-02-27 Invitrogen Corp Compositions and methods for use in recombinational cloning of nucleic acids
CN1818070A (zh) * 1999-10-25 2006-08-16 茵维特罗根公司 使用转座和重组以操作和测序核酸分子的方法
EP1250453B1 (de) 1999-12-10 2008-04-09 Invitrogen Corporation Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
US6551828B1 (en) 2000-06-28 2003-04-22 Protemation, Inc. Compositions and methods for generating expression vectors through site-specific recombination
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7214515B2 (en) 2001-01-05 2007-05-08 The General Hospital Corporation Viral delivery system for infectious transfer of large genomic DNA inserts
WO2003029489A1 (en) * 2001-10-03 2003-04-10 Iseao Technologies Limited Methods for detection of target molecules and molecular interactions
AU2002361633A1 (en) * 2001-11-15 2003-06-10 Aventis Pharmaceuticals Inc. Genetically modified bacterial strains and novel vectors for use in expressing and assaying natural products
US6818420B2 (en) 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
US20080076678A1 (en) * 2005-06-15 2008-03-27 Philippe Soucaille Method of creating a library of bacterial clones with varying levels of gene expression
EP1543128A4 (de) * 2002-07-18 2008-02-20 Invitrogen Corp Virusvektoren mit rekombinationsstellen
EP1475437A4 (de) * 2002-12-10 2005-06-01 Kazusa Dna Res Inst Foundation Verfahren zur effizienten rekombination eines durch cdna codierten orf und eines matrizenvektors, dabei zu verwendender trap-vektor und primer
JP2006525817A (ja) * 2003-05-09 2006-11-16 ヘルス　リサーチ　インコーポレイテッド タンパク質の相互作用の決定のための改良法
EP1697534B1 (de) 2003-12-01 2010-06-02 Life Technologies Corporation Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
GB0424356D0 (en) * 2004-11-03 2004-12-08 Ark Therapeutics Ltd Baculovirus-based gene libraries
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
US20080248565A1 (en) * 2007-03-01 2008-10-09 Invitrogen Corporation Isolated phospholipid-protein particles
WO2007137300A2 (en) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
WO2008059005A2 (en) * 2006-11-17 2008-05-22 Agriculture Victoria Services Pty. Ltd. Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof
EP2217710A1 (de) 2007-11-30 2010-08-18 Boehringer Ingelheim Pharma GmbH & Co. KG Neuartige rekombinationssequenzen
US20090280103A1 (en) * 2008-04-04 2009-11-12 Martin Flueck Regulation of muscle repair
EP2449091A4 (de) 2009-07-02 2012-12-05 Verdezyne Inc Biologische verfahren zur herstellung von adipinsäure
IN2012DN00568A (de) * 2009-07-09 2015-06-12 Verdzyne Inc
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US10100318B2 (en) * 2009-11-13 2018-10-16 Massachusetts Institute Of Technology Bio-field programmable gate array and bio-programmable logic array: reconfigurable chassis construction
EP2513304A2 (de) 2009-12-16 2012-10-24 University Of Washington Toxinimmunitätssystem
WO2011074960A1 (en) * 2009-12-17 2011-06-23 Keygene N.V. Restriction enzyme based whole genome sequencing
US20120202244A1 (en) * 2010-10-15 2012-08-09 Carnegie Institution Of Washington Antibodies Capable of Specifically Binding to a Specific Amino Acid Sequence
US8728798B2 (en) 2011-05-03 2014-05-20 Verdezyne, Inc. Biological methods for preparing adipic acid
US8343752B2 (en) 2011-05-03 2013-01-01 Verdezyne, Inc. Biological methods for preparing adipic acid
US11767534B2 (en) * 2011-05-04 2023-09-26 The Broad Institute, Inc. Multiplexed genetic reporter assays and compositions
MY184871A (en) 2011-07-06 2021-04-28 Radici Chimica S P A Biological methods for preparing a fatty dicarboxylic acid
US9816077B2 (en) 2011-08-03 2017-11-14 Ramot At Tel-Aviv University Ltd. Use of integrase for targeted gene expression
CN103945931B (zh) 2011-09-26 2017-03-22 基因技术股份公司 高效的小体积核酸合成
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
US9465519B2 (en) 2011-12-21 2016-10-11 Life Technologies Corporation Methods and systems for in silico experimental designing and performing a biological workflow
WO2013152220A2 (en) 2012-04-04 2013-10-10 Life Technologies Corporation Tal-effector assembly platform, customized services, kits and assays
TWI638047B (zh) 2014-04-09 2018-10-11 史基普研究協會 藉由核酸三磷酸酯轉運子將非天然或經修飾的核苷三磷酸酯輸入至細胞中
FR3028527A1 (fr) 2014-11-13 2016-05-20 Pivert Identification de facteurs de transcription de yarrowia lipolytica
CN115927293A (zh) 2014-12-09 2023-04-07 生命技术公司 高效小体积核酸合成
KR20200108514A (ko) * 2015-09-17 2020-09-21 코다 바이오테라퓨틱스 인코포레이티드 신경 장애를 치료하기 위한 조성물 및 방법
WO2017106767A1 (en) 2015-12-18 2017-06-22 The Scripps Research Institute Production of unnatural nucleotides using a crispr/cas9 system
US11549119B2 (en) * 2016-04-06 2023-01-10 Zumutor Biologics, Inc. Vectors for cloning and expression of proteins, methods and applications thereof
EP4219709A1 (de) * 2016-11-03 2023-08-02 Temple University - Of The Commonwealth System of Higher Education Dna plasmide für die schnelle herstellung von homologen rekombinationsvektoren für zelllinienentwicklung
EP3609524A4 (de) * 2017-04-14 2021-01-27 Rhode Island Hospital Vegf-gentherapie für sehnen- und bänderverletzungen
SG11202000167SA (en) 2017-07-11 2020-02-27 Synthorx Inc Incorporation of unnatural nucleotides and methods thereof
AU2018309166B2 (en) 2017-08-03 2022-12-08 Synthorx, Inc. Cytokine conjugates for the treatment of proliferative and infectious diseases
MX2021009259A (es) 2019-02-06 2021-08-24 Synthorx Inc Conjugados de il-2 y metodos de uso del mismo.
CN114207229A (zh) * 2019-05-30 2022-03-18 快速基因组学有限责任公司 靶基因组区域的灵活且高通量的测序
US20200405829A1 (en) 2019-06-28 2020-12-31 Massachusetts Institute Of Technology Circular strained zymogen compositions and methods of use

Family Cites Families (192)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576463A (en) * 1897-02-02 maloney
US4626505A (en) 1984-02-24 1986-12-02 E. I. Du Pont De Nemours And Company Selectable markers for yeast transformation
US4673640A (en) 1984-04-30 1987-06-16 Biotechnica International, Inc. Regulated protein production using site-specific recombination
US4808537A (en) 1984-10-30 1989-02-28 Phillips Petroleum Company Methanol inducible genes obtained from pichia and methods of use
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4743546A (en) 1985-02-13 1988-05-10 Biotechnica International, Inc. Controlled gene excision
IT8520964V0 (it) 1985-03-01 1985-03-01 Alfa Romeo Spa Contenitore per il liquido lavavetri di un autoveicolo.
US5200333A (en) 1985-03-01 1993-04-06 New England Biolabs, Inc. Cloning restriction and modification genes
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3688920D1 (de) 1985-07-03 1993-09-30 Genencor Int Hybride Polypeptide und Verfahren zu deren Herstellung.
US6121043A (en) 1985-09-06 2000-09-19 Syntro Corporation Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
DE3876327D1 (de) 1987-07-21 1993-01-14 Du Pont Merck Pharma Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren.
US4960707A (en) 1987-08-17 1990-10-02 Associated Universities, Inc. Recombinant plasmids for encoding restriction enzymes DpnI and DpnII of streptococcus pneumontae
US5244797B1 (en) 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
JPH03503482A (ja) 1988-02-12 1991-08-08 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション ポックスウイルスベクター
US5378618A (en) 1988-04-15 1995-01-03 E. I. Du Pont De Nemours And Company Vitro headful packaging system for cloning DNA fragments as large as 95kb
US5139942A (en) 1988-05-19 1992-08-18 New England Biolabs, Inc. Method for producing the nde i restriction endonuclease and methylase
US5334375A (en) 1988-12-29 1994-08-02 Colgate Palmolive Company Antibacterial antiplaque oral composition
DE3901681A1 (de) 1989-01-21 1990-07-26 Behringwerke Ag Signalpeptid fuer die sekretion von peptiden in escherichia coli, verfahren zu seiner gewinnung und seine verwendung
CA2012983A1 (en) 1989-03-27 1990-09-27 Sydney Brenner Process for nucleic acid detection by binary amplification
EP0394827A1 (de) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide
US5102797A (en) 1989-05-26 1992-04-07 Dna Plant Technology Corporation Introduction of heterologous genes into bacteria using transposon flanked expression cassette and a binary vector system
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
DE68920335T2 (de) 1989-08-22 1995-06-29 E.I. Du Pont De Nemours & Co., Wilmington, Del. In vitro-verpackungsvorrichtung um dna-fragmente von 95-kb zu klonen.
NO904633L (no) 1989-11-09 1991-05-10 Molecular Diagnostics Inc Amplifikasjon av nukleinsyrer ved transkriberbar haarnaalsprobe.
AU639059B2 (en) 1989-12-22 1993-07-15 E.I. Du Pont De Nemours And Company Site-specific recombination of dna in plant cells
US5658772A (en) 1989-12-22 1997-08-19 E. I. Du Pont De Nemours And Company Site-specific recombination of DNA in plant cells
DE69033732T2 (de) 1990-01-08 2001-10-11 Stratagene, La Jolla Neue Wirtsorganismen zur Klonierung
US5192675A (en) 1990-03-20 1993-03-09 Life Technologies, Inc. Cloned KpnI restriction-modification system
US5082784A (en) 1990-03-20 1992-01-21 Life Technologies, Inc. Cloned kpni restriction-modification system
WO1991016427A1 (en) 1990-04-24 1991-10-31 Stratagene Methods for phenotype creation from multiple gene populations
US5451513A (en) 1990-05-01 1995-09-19 The State University of New Jersey Rutgers Method for stably transforming plastids of multicellular plants
US5098839A (en) 1990-05-10 1992-03-24 New England Biolabs, Inc. Type ii restriction endonuclease obtainable from pseudomonas alcaligenes and a process for producing the same
US5147800A (en) 1990-06-08 1992-09-15 Life Technologies, Inc. Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria
CA2109602C (en) 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
US5179015A (en) 1990-07-23 1993-01-12 New England Biolabs, Inc. Heterospecific modification as a means to clone restriction genes
US5227288A (en) * 1990-10-01 1993-07-13 Blattner Frederick R DNA sequencing vector with reversible insert
US5202248A (en) 1990-11-02 1993-04-13 New England Biolabs, Inc. Method for cloning and producing the nco i restriction endonuclease and methylase
US5286632A (en) 1991-01-09 1994-02-15 Jones Douglas H Method for in vivo recombination and mutagenesis
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5871907A (en) 1991-05-15 1999-02-16 Medical Research Council Methods for producing members of specific binding pairs
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
US5962255A (en) 1992-03-24 1999-10-05 Cambridge Antibody Technology Limited Methods for producing recombinant vectors
WO1992022650A1 (en) 1991-06-17 1992-12-23 Life Technologies, Inc. Recombination-facilitated multiplex analysis of dna fragments
GB9123929D0 (en) 1991-11-11 1992-01-02 Wellcome Found Novel expression system
EP0626999A4 (en) 1992-01-24 1997-04-09 Life Technologies Inc Modulation of enzyme activities in the -i(in vivo) cloning of dna.
ATE201236T1 (de) 1992-02-26 2001-06-15 Zeneca Mogen B V Zur ortsspezifischen rekomination fähige agrobakterium stämme
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
DE69333823T2 (de) 1992-03-24 2006-05-04 Cambridge Antibody Technology Ltd., Melbourn Verfahren zur herstellung von gliedern von spezifischen bindungspaaren
US5231021A (en) 1992-04-10 1993-07-27 Life Technologies, Inc. Cloning and expressing restriction endonucleases and modification methylases from xanthomonas
BE1006085A3 (fr) 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
US7176029B2 (en) 1992-07-31 2007-02-13 Universite Libre De Bruxelles Cloning and/or sequencing vector
US5733733A (en) 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
WO1994003624A1 (en) 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US5614389A (en) 1992-08-04 1997-03-25 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5348886A (en) 1992-09-04 1994-09-20 Monsanto Company Method of producing recombinant eukaryotic viruses in bacteria
US6225121B1 (en) 1992-09-14 2001-05-01 Institute Of Molecular Biology And Biotechnology/Forth Eukaryotic transposable element
US5338671A (en) 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
WO1994009127A2 (en) 1992-10-16 1994-04-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Healthand Human Services Supercoiled minicircle dna as as a unitary promoter vector
CA2150262C (en) 1992-12-04 2008-07-08 Kaspar-Philipp Holliger Multivalent and multispecific binding proteins, their manufacture and use
US5248605A (en) 1992-12-07 1993-09-28 Life Technologies, Inc. Cloning and expressing restriction endonucleases from haemophilus
US5334575A (en) 1992-12-17 1994-08-02 Eastman Kodak Company Dye-containing beads for laser-induced thermal dye transfer
US5312746A (en) 1993-01-08 1994-05-17 Life Technologies, Inc. Cloning and expressing restriction endonucleases and modification methylases from caryophanon
US5527695A (en) 1993-01-29 1996-06-18 Purdue Research Foundation Controlled modification of eukaryotic genomes
GB9302798D0 (en) 1993-02-12 1993-03-31 Medical Res Council Improvements in or relating to cloning dna
AU6359894A (en) 1993-03-05 1994-09-26 Crop Genetics International Corporation Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same
US5334526A (en) 1993-05-28 1994-08-02 Life Technologies, Inc. Cloning and expression of AluI restriction endonuclease
US5919676A (en) 1993-06-24 1999-07-06 Advec, Inc. Adenoviral vector system comprising Cre-loxP recombination
US6140087A (en) 1993-06-24 2000-10-31 Advec, Inc. Adenovirus vectors for gene therapy
US6120764A (en) 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
EP0632054A1 (de) 1993-06-28 1995-01-04 European Molecular Biology Laboratory Regulation stellenspezifischer Rekombination mittels stellungsspezifischer Rekombinase/Kernrezeptor-Fusionsproteine
US5441884A (en) 1993-07-08 1995-08-15 Ecogen Inc. Bacillus thuringiensis transposon TN5401
US5843744A (en) 1993-07-08 1998-12-01 Ecogen Inc. Bacillus thuringiensis Tn5401 proteins
US5470740A (en) 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
US5470727A (en) 1993-12-21 1995-11-28 Celtrix Pharmaceuticals, Inc. Chromosomal expression of non-bacterial genes in bacterial cells
US5861273A (en) 1993-12-21 1999-01-19 Celtrix Phamraceuticals, Inc. Chromosomal expression of heterologous genes in bacterial cells
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5677170A (en) 1994-03-02 1997-10-14 The Johns Hopkins University In vitro transposition of artificial transposons
WO1995032225A1 (en) 1994-05-23 1995-11-30 The Salk Institute For Biological Studies Method for site-specific integration of nucleic acids and related products
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
EG23907A (en) 1994-08-01 2007-12-30 Delta & Pine Land Co Control of plant gene expression
US5723765A (en) 1994-08-01 1998-03-03 Delta And Pine Land Co. Control of plant gene expression
US5627024A (en) * 1994-08-05 1997-05-06 The Scripps Research Institute Lambdoid bacteriophage vectors for expression and display of foreign proteins
US5589618A (en) 1994-09-01 1996-12-31 University Of Florida Materials and methods for increasing corn seed weight
US5534428A (en) 1994-09-06 1996-07-09 Life Technologies, Inc. Cloned Ssti/SacI restriction-modification system
FR2727689A1 (fr) 1994-12-01 1996-06-07 Transgene Sa Nouveau procede de preparation d'un vecteur viral
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
US5981177A (en) 1995-01-25 1999-11-09 Demirjian; David C. Protein fusion method and constructs
US5814300A (en) 1995-03-03 1998-09-29 Cephalon, Inc. Gene-targeted non-human mammals deficient in the SOD-1 gene
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US5695971A (en) 1995-04-07 1997-12-09 Amresco Phage-cosmid hybrid vector, open cos DNA fragments, their method of use, and process of production
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
ES2181900T3 (es) 1995-06-07 2003-03-01 Invitrogen Corp Clonacion recombinante in vitro usanto sitios de recombinacion por ingenieria genetica.
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US5750346A (en) 1995-08-07 1998-05-12 The Perkin-Elmer Corporation Host organism capture
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
AUPN523995A0 (en) 1995-09-05 1995-09-28 Crc For Biopharmaceutical Research Pty Ltd Method for producing phage display vectors
AU716781B2 (en) 1995-10-13 2000-03-09 Purdue Research Foundation Method for the production of hybrid plants
US6156497A (en) 1996-01-05 2000-12-05 Genetic Therapy, Inc. Recombinase-mediated generation of adenoviral vectors
WO1997032481A1 (en) 1996-03-07 1997-09-12 The Regents Of The University Of California Helper-free, totally defective adenovirus for gene therapy
US5928914A (en) 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
GB9614761D0 (en) 1996-07-13 1996-09-04 Schlumberger Ltd Downhole tool and method
US5710248A (en) 1996-07-29 1998-01-20 University Of Iowa Research Foundation Peptide tag for immunodetection and immunopurification
JP2001500014A (ja) 1996-09-06 2001-01-09 トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスの生産のためにｃｒｅ―ｌｏｘを用いる方法
US6025192A (en) 1996-09-20 2000-02-15 Cold Spring Harbor Laboratory Modified retroviral vectors
JP2002511732A (ja) 1996-10-11 2002-04-16 ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム トランスジェニック動物を発生させるための組成物および方法
US6066778A (en) 1996-11-06 2000-05-23 The Regents Of The University Of Michigan Transgenic mice expressing APC resistant factor V
US6303301B1 (en) 1997-01-13 2001-10-16 Affymetrix, Inc. Expression monitoring for gene function identification
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
US6410220B1 (en) 1997-02-28 2002-06-25 Nature Technology Corp Self-assembling genes, vectors and uses thereof
EP2251347A3 (de) 1997-04-22 2011-02-23 Life Technologies Corporation Verfahren zur Herstellung von aus mehreren Untereinheiten zusammengesetzten ASLV-Umkehrtranskriptasen
DE19720839B4 (de) 1997-05-17 2007-08-16 Dirk Dr. Schindelhauer Baukastenprinzip-Technologie zur Herstellung von langen, exakten DNA-Konstrukten in vitro, insbesondere für die Herstellung von Konstrukten zur Erzeugung von künstlichen Chromosomen (MAC, mammalian artificial chromosome) aus zwei stabil klonierten DNA-Komponenten und der ditelomerische Vektor-Prototyp PTAT
US5989872A (en) 1997-08-12 1999-11-23 Clontech Laboratories, Inc. Methods and compositions for transferring DNA sequence information among vectors
US6140086A (en) 1997-08-15 2000-10-31 Fox; Donna K. Methods and compositions for cloning nucleic acid molecules
US7135608B1 (en) 1997-08-28 2006-11-14 The Salk Institute For Biological Studies Site-specific recombination in eukaryotes and constructs useful therefor
US6897066B1 (en) 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
CN101125873A (zh) 1997-10-24 2008-02-20 茵维特罗根公司 利用具重组位点的核酸进行重组克隆
DE69836092T2 (de) 1997-10-24 2007-05-10 Invitrogen Corp., Carlsbad Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US20030124555A1 (en) 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
JP4206154B2 (ja) 1997-11-13 2009-01-07 大日本住友製薬株式会社 変異型ｌｏｘＰ配列とその応用
US6262341B1 (en) 1997-11-18 2001-07-17 Pioneer Hi-Bred International, Inc. Method for the integration of foreign DNA into eukaryotic genomes
US5874259A (en) 1997-11-21 1999-02-23 Wisconsin Alumni Research Foundation Conditionally amplifiable BAC vector
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
DE69822206T2 (de) 1997-12-19 2005-02-17 Affymetrix, Inc., Santa Clara Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
US6436707B1 (en) 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
US6080576A (en) 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
WO1999055851A2 (en) 1998-04-28 1999-11-04 Novartis Ag Site-directed transformation of plants
SE9802454D0 (sv) 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
AU5584999A (en) 1998-08-28 2000-03-21 Invitrogen Corporation System for the rapid manipulation of nucleic acid sequences
AU1721600A (en) * 1998-11-13 2000-06-05 Life Technologies, Inc. Compositions and methods for recombinational cloning of nucleic acid molecules
US6576463B1 (en) 1999-01-15 2003-06-10 The Regents Of The University Of California Hybrid vectors for gene therapy
NZ514569A (en) * 1999-03-02 2004-02-27 Invitrogen Corp Compositions and methods for use in recombinational cloning of nucleic acids
EP1159402A4 (de) 1999-03-02 2003-01-29 Invitrogen Corp ZELLEN, WELCHE RESISTENT GEGENüBER TOXISCHEN GENEN SIND UND DEREN ANWENDUNGEN
AU3719500A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Recombination of insertion modified nucleic acids
EP1169458A2 (de) 1999-04-06 2002-01-09 Oklahoma Medical Research Foundation Verfahren zur selektion von rekombinase varianten mit veränderten spezifität
JP2003510019A (ja) 1999-07-14 2003-03-18 クロンテック・ラボラトリーズ・インコーポレーテッド リコンビナーゼを利用した発現ベクターを作製する方法、およびこの方法を実施するために使用する組成物
CA2379115C (en) 1999-07-23 2011-04-26 The Regents Of The University Of California Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system
AU6529900A (en) 1999-08-09 2001-03-05 Monsanto Technology Llc Novel cloning methods and vectors
DE19941186A1 (de) 1999-08-30 2001-03-01 Peter Droege Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen
CA2383423A1 (en) 1999-09-17 2001-03-22 Whitehead Institute For Biomedical Research Reverse transfection method
US20020006664A1 (en) 1999-09-17 2002-01-17 Sabatini David M. Arrayed transfection method and uses related thereto
GB9923558D0 (en) 1999-10-05 1999-12-08 Oxford Biomedica Ltd Producer cell
CN1818070A (zh) 1999-10-25 2006-08-16 茵维特罗根公司 使用转座和重组以操作和测序核酸分子的方法
EP1250453B1 (de) 1999-12-10 2008-04-09 Invitrogen Corporation Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
EP1504119A2 (de) 2000-02-25 2005-02-09 Stratagene California Verfahren zur ligation von nukleinsäuren und molekularer klonierung
IL151781A0 (en) 2000-03-16 2003-04-10 Genetica Inc Methods and compositions for rna interference
US7244560B2 (en) 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20020068290A1 (en) 2000-05-31 2002-06-06 Timur Yarovinsky Topoisomerase activated oligonucleotide adaptors and uses therefor
US6551828B1 (en) 2000-06-28 2003-04-22 Protemation, Inc. Compositions and methods for generating expression vectors through site-specific recombination
GB0016747D0 (en) 2000-07-08 2000-08-30 Johnson Matthey Plc Ink
CA2417130A1 (en) 2000-07-25 2002-01-31 National Research Council Of Canada Glycerol-3-phosphate/dihydroxyacetone phosphate dual substrate acyltransferases
WO2003103600A2 (en) 2002-06-05 2003-12-18 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU8835601A (en) 2000-08-21 2002-03-04 Invitrogen Corp Methods and reagents for molecular cloning
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
CA2430886A1 (en) 2000-12-08 2002-08-08 Invitrogen Corporation Compositions and methods for rapidly generating recombinant nucleic acid molecules
US20060008817A1 (en) 2000-12-08 2006-01-12 Invitrogen Corporation Methods and compositions for generating recombinant nucleic acid molecules
EP1349917B1 (de) 2000-12-08 2010-03-10 Life Technologies Corporation Verfahren und zusammensetzungen zur synthese von nukleinsäuremolekülen unter verwendung multipler erkennungsstellen
AU2002311756A1 (en) 2001-01-18 2002-10-28 Clontech Laboratories, Inc. Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same
US20030176644A1 (en) 2001-02-07 2003-09-18 Devon Byrd Compositions and methods for molecular biology
AU2002235676B2 (en) * 2001-02-23 2006-10-26 Universite Libre De Bruxelles Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
EP1390394A4 (de) 2001-04-19 2004-05-26 Invitrogen Corp Zusammensetzungen und verfahren zur rekombinationsklonierung von nukleinsäuremolekülen
WO2003056293A2 (en) 2001-07-10 2003-07-10 Whitehead Institute For Biomedical Research Small molecule microarrays
WO2003025161A1 (en) 2001-09-18 2003-03-27 Clontech Laboratories, Inc. Site-specific recombinase based method for producing adenoviral vectors
US20030135888A1 (en) 2001-09-26 2003-07-17 Tong Zhu Genes that are modulated by posttranscriptional gene silencing
JP4210769B2 (ja) 2001-11-22 2009-01-21 独立行政法人産業技術総合研究所 Ｇａｔｅｗａｙエントリークローンの作製方法
US20030102346A1 (en) * 2001-12-04 2003-06-05 Mei-Lien Chen Pneumatic tool system operation and carrier belt
US7294504B1 (en) 2001-12-27 2007-11-13 Allele Biotechnology & Pharmaceuticals, Inc. Methods and compositions for DNA mediated gene silencing
WO2003066829A2 (en) 2002-02-07 2003-08-14 Discovery Genomics, Inc. Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof
US20040132133A1 (en) 2002-07-08 2004-07-08 Invitrogen Corporation Methods and compositions for the production, identification and purification of fusion proteins
EP1543128A4 (de) 2002-07-18 2008-02-20 Invitrogen Corp Virusvektoren mit rekombinationsstellen
WO2004013290A2 (en) 2002-08-05 2004-02-12 Invitrogen Corporation Compositions and methods for molecular biology
US20040253620A1 (en) 2003-04-30 2004-12-16 Invitrogen Corporation Use of site specific recombination to prepare molecular markers
EP1644538A4 (de) 2003-06-26 2006-11-08 Invitrogen Corp Verfahren und zusammensetzungen zum nachweis von promotoraktivität und zur expression von fusionsproteinen
EP1660631B1 (de) 2003-08-01 2013-04-24 Life Technologies Corporation Zusammensetzungen und verfahren zur aufreinigung kurzer rna-moleküle
EP2484687A3 (de) 2003-08-08 2012-11-14 Life Technologies Corporation Verfahren und Zusammensetzungen zum nahtlosen Klonieren von Nukleinsäuremolekülen
US20050176065A1 (en) 2003-10-22 2005-08-11 Invitrogen Corporation Target sequences for synthetic molecules
EP1697534B1 (de) 2003-12-01 2010-06-02 Life Technologies Corporation Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
US20060204979A1 (en) 2004-12-01 2006-09-14 Invitrogen Corporation Reverse two-hybrid system for identification of interaction domains
US8972161B1 (en) 2005-11-17 2015-03-03 Invent.Ly, Llc Power management systems and devices

Also Published As

Publication number Publication date
DE60042969D1 (de) 2009-10-29
NZ525134A (en) 2004-09-24
WO2000052027A1 (en) 2000-09-08
EP1173460A4 (de) 2004-05-19
JP2002537790A (ja) 2002-11-12
AU3614300A (en) 2000-09-21
EP1173460A1 (de) 2002-01-23
EP2336148A1 (de) 2011-06-22
US20150093787A1 (en) 2015-04-02
US7670823B1 (en) 2010-03-02
AU2004214624A1 (en) 2004-10-21
US20110033920A1 (en) 2011-02-10
EP2119788A1 (de) 2009-11-18
NZ514569A (en) 2004-02-27
JP4580106B2 (ja) 2010-11-10
EP1173460B1 (de) 2009-09-16
CA2363924A1 (en) 2000-09-08
US8241896B2 (en) 2012-08-14
US8883988B2 (en) 2014-11-11
US20130059342A1 (en) 2013-03-07
AU774643B2 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
DE60042969D1 (de) Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
CY1112334T1 (el) Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων
DE69635444D1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
DK1294876T3 (da) EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
WO2002026822A3 (en) Pumpcn compositions and uses thereof
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE60043428D1 (de) POLYPEPTIDE MIT VERZWEIGUNGSENZYM-AKTIVITäT UND FüR DIESE KODIERENDE NUKLEINSäUREN
ATE439431T1 (de) Zusammenstellung und verfahren zur diagnose von tumoren
WO2002016611A3 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
WO2000043419A3 (en) Exocytosis pathway proteins and methods of use
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
DE60018605D1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein, sowie zusammensetzungen, verfahren und verwendungen
PT1277833E (pt) Gene que e amplificado em tumores e materiais e metodos relacionados
DK1241252T3 (da) Nucleinsyrer, der opformeres i tumorer samt relaterede materialer og fremgangsmåder
DK1249491T3 (da) Nucleinsyre, der opformeres i humane tumorer samt beslægtede materialer og fremgangsmåder
DE69937756D1 (de) Menschliches Prostasin-ähnliches Protein und dafür kodierende Nukleinsäure
ATE409225T1 (de) Durch wnt-1 induzierbare gene
DK1241185T3 (da) Nucleinsyrer, der er opformeret i humane tumorer, samt beslægtede materialer og fremgangsmåder
DE60038986D1 (de) Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties